My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.

    Lüke M, Januschowski K, Warga M, Beutel J, Leitritz M, Gelisken F, Grisanti S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P; for the Tuebingen Bevacizumab Study Group.

    Br J Ophthalmol. 2007 Aug;91(8):1077-82. Epub 2007 Mar 23.PMID: 17383998 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effects of bevacizumab on retinal function in isolated vertebrate retina.

    Lüke M, Warga M, Ziemssen F, Gelisken F, Grisanti S, Schneider T, Lüke C, Partsch M, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group.

    Br J Ophthalmol. 2006 Sep;90(9):1178-82. Epub 2006 Jun 5.PMID: 16754646 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke C, Bartz-Schmidt KU, Grisanti S, Szurman P.

    Br J Ophthalmol. 2009 Oct;93(10):1396-400. Epub 2009 Jul 23.PMID: 19628500 [PubMed - indexed for MEDLINE]Related articles

    4.

    The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P.

    Exp Eye Res. 2008 Jul;87(1):22-9. Epub 2008 Apr 23.PMID: 18514644 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of the protein tyrosine kinase inhibitor genistein and taurine on retinal function in isolated superfused retina.

    Lüke M, Krott R, Warga M, Szurman P, Grisanti S, Bartz-Schmidt KU, Schneider T, Lüke C.

    Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):242-8.PMID: 16453129 [PubMed - indexed for MEDLINE]Related articles

    6.

    Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.

    Lüke M, Januschowski K, Beutel J, Lüke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):817-22. Epub 2008 Jan 16.PMID: 18197412 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of daunorubicin and CD95L on retinal function in superfused vertebrate retina.

    Hueber A, Lüke M, Esser PJ, Kirchhof B, Sickel W, Lüke C.

    J Ocul Pharmacol Ther. 2005 Apr;21(2):133-8.PMID: 15857279 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of the phosphodiesterase type V inhibitor sildenafil on human and bovine retinal function in vitro.

    Lüke M, Szurman P, Schneider T, Lüke C.

    Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1211-5.PMID: 17345091 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of protein tyrosine kinase inhibitor genistein on retinal function in superfused vertebrate retina.

    Lüke C, Krott R, Lüke M, Lebek J, Walter P, Brunner R, Sickel W.

    J Ocul Pharmacol Ther. 2001 Apr;17(2):151-8.PMID: 11324982 [PubMed - indexed for MEDLINE]Related articles

    10.

    Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.

    Graham DA, Huang TC, Keyt BA, Alevriadou BR.

    Ann Biomed Eng. 1998 Jul-Aug;26(4):712-24.PMID: 9662163 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.

    Meyer CH, Scholl HP, Eter N, Helb HM, Holz FG.

    Acta Ophthalmol. 2008 Aug;86(5):490-4. Epub 2008 Jan 24.PMID: 18221499 [PubMed - indexed for MEDLINE]Related articles

    12.

    A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.

    Kamei M, Misono K, Lewis H.

    Am J Ophthalmol. 1999 Dec;128(6):739-46.PMID: 10612511 [PubMed - indexed for MEDLINE]Related articles

    13.

    Fibrinolysis of experimental subretinal haemorrhage without removal using tissue plasminogen activator.

    Morse LS, Benner JD, Hjelmeland LM, Landers MB 3rd.

    Br J Ophthalmol. 1996 Jul;80(7):658-62.PMID: 8795382 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.

    Joeres S, Kaplowitz K, Brubaker JW, Updike PG, Collins AT, Walsh AC, Romano PW, Sadda SR.

    Ophthalmology. 2008 Feb;115(2):347-354.e2. Epub 2007 Jul 12.PMID: 17628685 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of patent blue on human retinal function.

    Lüke C, Lüke M, Sickel W, Schneider T.

    Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1188-90. Epub 2006 Feb 17.PMID: 16485112 [PubMed - indexed for MEDLINE]Related articles

    16.

    Retinal tolerance to dyes.

    Lüke C, Lüke M, Dietlein TS, Hueber A, Jordan J, Sickel W, Kirchhof B.

    Br J Ophthalmol. 2005 Sep;89(9):1188-91.PMID: 16113379 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration.

    Benner JD, Hay A, Landers MB 3rd, Hjelmeland LM, Morse LS.

    Ophthalmology. 1994 Apr;101(4):672-81.PMID: 8152762 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.

    Hattenbach LO, Klais C, Koch FH, Gümbel HO.

    Ophthalmology. 2001 Aug;108(8):1485-92.PMID: 11470706 [PubMed - indexed for MEDLINE]Related articles

    19.

    Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?

    Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS 3rd, Cacayorin ED, Grotta JC, Noser EA.

    Stroke. 2007 Jan;38(1):80-4. Epub 2006 Nov 22.PMID: 17122433 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [The intravitreal application of the tissue plasminogen activator in the treatment of submacular hemorrhage--a case report]

    Fric E, Sín M, Rehák M, Chrapek O, Simicák J, Fehák J.

    Cesk Slov Oftalmol. 2008 Nov;64(6):237-40. Czech. PMID: 19110965 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity